article thumbnail

Pharma R&D investment report shows positive signs: Deloitte

Outsourcing Pharma

According to the companyĆ¢s 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.

article thumbnail

Despite COVID-19, pharma R&D funding at all-time high: IQVIA

Outsourcing Pharma

According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels.

article thumbnail

Innovation in insulin delivery: Two companies look to transform diabetes treatment

BioPharma Reporter

Multiple pharma R&D teams are seeking to transform how diabetes treatment is managed.